Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
53 hedge funds and large institutions have $21.6M invested in Applied Therapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 26 closing their positions.
10.73% more ownership
Funds ownership: 47.1% → 57.83% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less call options, than puts
Call options by funds: $14K | Put options by funds: $16K
17% less capital invested
Capital invested by funds: $26M → $21.6M (-$4.45M)
25% less funds holding
Funds holding: 71 → 53 (-18)
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
62% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.13M |
| 2 |
O
OrbiMed
New York
|
+$6.96M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$5.21M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.08M |
| 5 |
EAM
Empery Asset Management
New York
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.43M |
| 2 |
State Street
Boston,
Massachusetts
|
-$544K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$211K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$205K |
| 5 |
Two Sigma Investments
New York
|
-$167K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$1 | -393 | Closed |
|
|
AF
77
Allworth Financial
Folsom,
California
| – | +$409 | +250 | New |
|
APLT Hedge Fund Activity: Q2 2022 in Review
53 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2022, worth a combined $21.6M — down 17% from $26M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of APLT and 10 opened new positions — a net loss of 16 holders — while 20 trimmed existing stakes and 14 added.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $7.13M. The largest seller was BlackRock, cutting an estimated $1.43M.
- 53 institutional investors held Applied Therapeutics (APLT) as of Q2 2022, down from 71 in Q1 2022.
- Funds reported $21.6M of Applied Therapeutics stock for Q2 2022, down 17% quarter-over-quarter.
- 10 funds opened new Applied Therapeutics positions in Q2 2022 and 26 closed out, a net change of -16 holders.
- The largest Applied Therapeutics buyer in Q2 2022 was Alyeska Investment Group, an estimated $7.13M added.
- The largest Applied Therapeutics seller in Q2 2022 was BlackRock, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2022.